
Lucy Safi, DO
Cardiovascular Disease (Heart Disease), Nuclear Cardiology, Echocardiography
About Me
Lucy M. Safi, DO, FACC, FASE, FSCAI joined the Cardiovascular Institute, Mount Sinai Heart as a fulltime faculty in April 2023, in the role of Assistant Professor of Medicine and currently works as an echocardiographer and structural heart interventional echocardiography. Dr. Safi completed Cardiovascular Diseases fellowship at Cooper University Hospital where she was selected as both Chief Cardiology Fellow and Chief GME Fellow. Subsequently, she completed an advanced echocardiography fellowship at the Massachusetts General Hospital. Prior to joining Mount Sinai, Dr. Safi was Director of Interventional Echocardiography at Hackensack University Medical Center. Her research interests focus on valvular heart disease, structural heart imaging, and artificial intelligence in echo. Dr. Safi has been an active member in the American Society of Echocardiography (ASE) for many years and has served on numerous ASE councils and committees, currently serving on the ASE education committee and ASE scientific Sessions planning committee. She is a graduate of the inaugural ASE leadership academy and was recently elected as a member of the ASE Board of Directors.
Telephone:212-241-6846
Email: lucy.safi@mountsinai.org
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Research Topics
Imaging
About Me
Lucy M. Safi, DO, FACC, FASE, FSCAI joined the Cardiovascular Institute, Mount Sinai Heart as a fulltime faculty in April 2023, in the role of Assistant Professor of Medicine and currently works as an echocardiographer and structural heart interventional echocardiography. Dr. Safi completed Cardiovascular Diseases fellowship at Cooper University Hospital where she was selected as both Chief Cardiology Fellow and Chief GME Fellow. Subsequently, she completed an advanced echocardiography fellowship at the Massachusetts General Hospital. Prior to joining Mount Sinai, Dr. Safi was Director of Interventional Echocardiography at Hackensack University Medical Center. Her research interests focus on valvular heart disease, structural heart imaging, and artificial intelligence in echo. Dr. Safi has been an active member in the American Society of Echocardiography (ASE) for many years and has served on numerous ASE councils and committees, currently serving on the ASE education committee and ASE scientific Sessions planning committee. She is a graduate of the inaugural ASE leadership academy and was recently elected as a member of the ASE Board of Directors.
Telephone:212-241-6846
Email: lucy.safi@mountsinai.org
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Research Topics
Imaging
Clinical Focus
- Cardiovascular Disease
- Echocardiogram/Transesophageal Echocardiography
- Echocardiography
- Electrocardiogram
- Valvular Heart Disease
Education
DO, Philadelphia College of Osteopathic Medicine
Residency, Internal Medicine
Lehigh Valley Health Network
Fellowship, Cardiovascular Disease
Cooper University Hospital
Fellowship, Echocardiography
Massachusetts General Hospital
Certifications
American Board of Internal Medicine
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Safi did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Safi did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.